These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 3778805)

  • 1. In vitro cytotoxicity patterns of standard and investigational agents on human bone marrow granulocyte-macrophage progenitor cells.
    Ajani JA; Spitzer G; Tomasovic B; Drewinko B; Hug VM; Dicke K
    Br J Cancer; 1986 Oct; 54(4):607-13. PubMed ID: 3778805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-survival curves of cis-platinum, melphalan, and velban in human granulocyte/macrophage progenitor cells.
    Umbach GE; Singletary SE; Tomasovic B; Spitzer G; Hug V; Drewinko B
    Int J Cell Cloning; 1984 Nov; 2(6):335-40. PubMed ID: 6542929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cytotoxic drugs on the development of murine granulocyte-macrophage (GM) progenitor cells.
    Cylwik B; Szmitkowski M
    Mater Med Pol; 1992; 24(4):262-5. PubMed ID: 1308058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of human bone marrow cells after in vitro treatment with 12 anticancer drugs and implications for tumor drug sensitivity assays.
    Umbach GE; Hug V; Spitzer G; Tomasovic B; Thames H; Ajani JA; Drewinko B
    J Cancer Res Clin Oncol; 1985; 109(2):130-4. PubMed ID: 3980561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
    Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU
    Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Action of granulopoiesis-stimulating cytokines rhG-CSF, rhGM-CSF, and rmGM-CSF on murine haematopoietic progenitor cells for granulocytes and macrophages (GM-CFC).
    Hofer M; Vacek A; Weiterová L
    Physiol Res; 2005; 54(2):207-13. PubMed ID: 15544422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of the Cdk-inhibitor roscovitine on mouse hematopoietic progenitors in vivo and in vitro.
    Song H; Vita M; Sallam H; Tehranchi R; Nilsson C; Sidén A; Hassan Z
    Cancer Chemother Pharmacol; 2007 Nov; 60(6):841-9. PubMed ID: 17318617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential sensitivity of adherent CFU-blast, CFU-mix, BFU-E, and CFU-GM to mafosfamide: implications for adjusted dose purging in autologous bone marrow transplantation.
    Carlo-Stella C; Mangoni L; Almici C; Garau D; Craviotto L; Piovani G; Caramatti C; Rizzoli V
    Exp Hematol; 1992 Mar; 20(3):328-33. PubMed ID: 1568448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of acetaldophosphamide, a novel stable aldophosphamide analogue, on normal human and leukemic progenitor cells in vitro: implications for use in bone marrow purging.
    Beran M; Andersson BS; Wang Y; McCredie KB; Farquhar D
    Cancer Res; 1988 Jan; 48(2):339-45. PubMed ID: 3275495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of glucocorticoids on the development of murine granulocyte-macrophage (GM) progenitors.
    Cylwik B; Szmitkowski M; Chrostek L
    Mater Med Pol; 1992; 24(1):14-6. PubMed ID: 1308262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antitumor activity of standard and investigational drugs at equivalent granulocyte-macrophage colony-forming cell inhibitory concentrations in the adhesive tumor cell culture system: an in vitro method of screening new drugs.
    Fan D; Ajani JA; Baker FL; Tomasovic B; Brock WA; Spitzer G
    Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1469-76. PubMed ID: 2890527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage inflammatory protein 1alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cells.
    Clemons M; Watson A; Howell A; Chang J; Heyworth C; Lord B; Testa N; Dexter TM; Margison G
    Clin Cancer Res; 2000 Mar; 6(3):966-70. PubMed ID: 10741722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 promotes macrophage development by rapidly stimulating lineage restriction of bipotent granulocyte-macrophage colony-forming cells.
    Nicholls SE; Heyworth CM; Dexter TM; Lord JM; Johnson GD; Whetton AD
    J Immunol; 1995 Jul; 155(2):845-53. PubMed ID: 7608562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential cytotoxic activity of chemotherapy agents on colony-forming cells from human tumors and normal bone marrow in vitro.
    Ajani JA; Blaauw AA; Spitzer G; Baker FL; Tomasovic B; Umbach G; Thielvoldt D; Zander AR; Dicke KA
    Exp Hematol; 1985; 13 Suppl 16():95-100. PubMed ID: 2580731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor.
    Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro.
    Benko I; Hernádi F; Megyeri A; Kiss A; Somogyi G; Tegyey Z; Kraicsovits F; Kovács P
    J Antimicrob Chemother; 1999 May; 43(5):675-81. PubMed ID: 10382889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of schedule on diethyldithiocarbamate modulation of drug-induced myelosuppression.
    East CJ; Borch RF
    Cancer Chemother Pharmacol; 1992; 31(2):123-6. PubMed ID: 1333368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suitability of a new stable acetal analogue of aldoifosphamide for purging leukemic cells from human bone marrow.
    Andersson BS; Wang YQ; McCredie KB; Farquhar D
    Leukemia; 1990 Jun; 4(6):435-40. PubMed ID: 2359343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bryostatin 1 on the in vitro radioprotective capacity of recombinant granulocyte-macrophage colony-stimulating factor (rGM-CSF) toward committed human myeloid progenitor cells (CFU-GM).
    Grant S; Pettit GR; McCrady C
    Exp Hematol; 1992 Jan; 20(1):34-42. PubMed ID: 1374343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responses of human bone marrow progenitor cells to fluoro-ara-AMP, homoharringtonine, and elliptinium.
    Umbach GE; Hug V; Spitzer G; Thames H; Drewinko B
    Invest New Drugs; 1984; 2(3):263-5. PubMed ID: 6210262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.